MedPath
NMPA Approval

Hemarisin for Injection

国药准字H22026347

September 18, 2024

Drug Information

注射用灵杆菌多糖

注射剂

50活性单位

化学药品

September 18, 2024

Company Information

Applicant Company

江西省赣江新区直管区中医药科创城公共研发中心10#楼第三层

Manufacturing Company

中山火炬开发区国家健康基地内健康路17号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.